用于快速检测高亲和力核酸序列的微阵列芯片。-猫眼课题宝

用于快速检测高亲和力核酸序列的微阵列芯片。

批准号：

7482692

负责人：

Mark Patrick McPike

金额：

$64.59万

依托单位：

APTAMATRIX, INC.

依托单位国家：

美国

项目类别：

财政年份：

2006

资助国家：

美国

项目状态：

已结题

起止时间：

2006-08-01 至 2010-04-30

来源：

https://reporter.nih.gov/project-details/7482692

关键词：

Affinity Amino Acid Sequence Animals Antibodies Antigens Area Base Sequence Binding Binding Proteins Biological Assay Biological Factors Bioterrorism Capillary Electrophoresis Cations Cell Line Classification Cloning Cryptosporidium DNA Diagnostic Engineering Event Gel Genetic Transcription Hand Image Kinetics Label Legal patent Libraries Licensing Life Marketing Measures Melanocytic nevus Methods Mole the mammal Molecular Probes Monoclonal Antibodies Nucleic Acid Probes Nucleic Acids Nucleic acid sequencing Nucleotides Oligonucleotides Optics Organism Peptide Sequence Determination Peptides Pharmacotherapy Phase Population Process Protein Array Proteins Protocols documentation Public Health RNA Resolution Reverse Transcription Screening procedure Set protein Signal Transduction Specificity Structure Surface Techniques Technology Time Work aptamer base biochip cellular targeting cofactor combinatorial commercialization concept design drug development drug discovery interest mimetics point of care pressure rapid detection sensor size stem

项目摘要

项目成果

Mark Patrick McPike的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

DESCRIPTION (provided by applicant): This Phase II project aims at further advancing and commercializing a microarray-based screening approach, for discovering nucleic acid probes that have high affinity and high specificity for protein and cellular targets. Oligonucleotides discovered in these screens can be engineered into sensors having exquisite sensitivity and selectivity for drug development, environmental sensing and POC-diagnostics; areas currently dominated by antibody based technologies. In Phase II we plan to pursue protein targets that are relevant to each of these market segments, in an effort streamline the commercialization process and establish a broad product portfolio. PUBLIC HEALTH RELEVANCE: The Combigen screening process being further developed in this phase II project will create molecular probes that specifically bind protein based targets. These probes will find applications in environmental sensing, point-of-care diagnostics and drug therapies.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文